Thus, the development of small molecules targeting these specific motifs may become a promising alternative to develop novel and specific ABCG2 efflux modulators able to tackle MDR in cancer by impairing drug-induced signal transmission, similar to what was recently suggested for P-gp66. Here, ABCG2 is linked to cancer.